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Fusion of a highly N-glycosylated 
polypeptide increases the 
expression of ER-localized proteins 
in plants
Hyangju Kang, Youngmin Park, Yongjik Lee, Yun-Joo Yoo & Inhwan Hwang
Plants represent promising systems for producing various recombinant proteins. One key area of focus 
for improving this technology is developing methods for producing recombinant proteins at high levels. 
Many methods have been developed to increase the transcript levels of recombinant genes. However, 
methods for increasing protein production involving steps downstream of transcription, including 
translation, have not been fully explored. Here, we investigated the effects of N-glycosylation on 
protein production and provide evidence that N-glycosylation greatly increases the expression levels of 
ER-targeted recombinant proteins. Fusion of the extracellular domain (M domain) of protein tyrosine 
phosphatase receptor type C (CD45), which contains four putative N-glycosylation sites to a model 
protein, leptin at the C-terminus, increased recombinant protein levels by 6.1 fold. This increase was 
specific to ER-targeted proteins and was dependent on N-glycosylation. Moreover, expression levels of 
leptin, leukemia inhibitory factor and GFP were also greatly increased by fusion of M domain at either 
the N or C-terminus. Furthermore, the increase in protein levels resulted from enhanced translation, 
but not transcription. Based on these results, we propose that fusing a small domain containing 
N-glycosylation sites to target proteins is a powerful technique for increasing the expression levels of 
recombinant proteins in plants.
Recombinant proteins are widely used for various purposes, including the treatment of human diseases1,2. Many 
important studies have led to the current state of recombinant protein production3,4. One limitation hampering 
the production of high-molecular-weight recombinant proteins is that only living organisms can successfully 
produce recombinant proteins on a commercial scale. Various types of cells have been successfully employed 
to produce recombinant proteins for commercial purposes. Bacteria were the first organisms to be developed 
as hosts for recombinant protein production, followed by animal cells and fungi. A recent addition to this list is 
plant cells, with the promise that recombinant proteins can be produced at low cost and high quality in terms of 
product safety5,6. Indeed, a plant-made pharmaceutical has recently come on the market, and many such products 
are currently undergoing clinical trials6. The overall process for producing recombinant proteins in plants is well 
established6–8.
Many techniques have been developed to produce recombinant proteins in plants. Recombinant genes 
can be stably inserted into the host nucleus or chloroplast genomes or transiently introduced into plants via 
Agrobacterium-mediated transformation9,10. In addition, recombinant proteins can be produced in whole plants 
or in transgenic cell cultures11. One advantage of producing recombinant proteins in plants is the low cost of these 
systems6. Indeed, the facilities required for plant growth can be less costly than those for animal cell culture12. 
However, the overall cost of producing recombinant proteins depends on many factors. One such factor is the 
expression levels of proteins in plant cells. Many expression vectors have been designed to produce proteins 
at high levels13. Most of these approaches largely rely on the presence of high transcript levels. One such tech-
nique is based on the use of plant RNA viruses14. In this vector system, target gene transcripts are amplified via 
RNA-based RNA polymerization. Another high-level production system involves chloroplast transformation, in 
which recombinant genes are inserted into the chloroplast genome. Using this approach, recombinant proteins 
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can comprise up to 70% of total leaf proteins15. Another component incorporated into high-level expression 
vectors is a transcription terminator, which helps stabilize the transcripts of interest16. Obtaining high transcript 
levels is crucial for high-level protein production. However, high transcript levels are not necessarily associated 
with high levels of protein production. The nucleotide sequence of the 5′ untranslated region (UTR) upstream of 
the coding region greatly affects the translational efficiency17. Thus, certain expression vectors contain transla-
tional enhancers, such as the omega sequence derived from tobacco mosaic virus18, or HT 5′ leader from mutated 
cowpea mosaic virus RNA-219. These enhancers help increase protein levels by enhancing the rate of translation.
The steps downstream of transcript accumulation leading to high levels of recombinant protein production 
in plants largely remain elusive. These steps involve efficient translation, trafficking, and targeting of the pro-
tein to organelles, as well as correct folding. N-glycosylation is a well-known protein modification that occurs 
in the endoplasmic reticulum (ER). The Asn residue of Asn-Xaa-Ser/Thr (Xaa, any amino acid except Pro) of 
ER-localized proteins can be glycosylated in the ER. The oligosaccharides on proteins are processed by many 
enzymes localized to the ER and Golgi apparatus, while these proteins are transported through the Golgi appara-
tus20. N-glycosylation plays a crucial role in protein folding20,21. When a nascent polypeptide is folded properly, 
it can be transported through the secretory pathway. By contrast, misfolded proteins in the ER are degraded by 
the 26S proteasome in the cytosol via ER-associated degradation (ERAD)22. Thus, N-glycosylation (involved in 
protein folding in the ER) may affect the expression levels of proteins. Consistent with this idea, cases have been 
reported that the deletion of N-glycosylation sites significantly reduces the expression levels of glycoproteins23,24. 
Conversely, in yeast, cutinase protein levels increased 5-fold and 1.8-fold when an N-glycosylation site was added 
to the N- or C-terminal region, respectively25. However, introducing N-glycosylation sites to recombinant pro-
teins does not always lead to higher levels of protein production. In the case of the propeptide of recombinant 
Pseudomonas aeruginosa elastase (rPAE), N-glycosylation at amino acid position 51 or 93 increased protein 
levels, whereas N-glycosylation at amino acid position 11 or 127 reduced protein levels26. Thus, the effect of 
N-glycosylation on recombinant protein production has not been fully elucidated.
In this study, we investigated the effects of the fusion of a highly N-glycosylated peptide on recombinant pro-
tein expression in plants. We fused leptin which is important hormone for regulating obesity as a model protein 
with a small extracellular domain, the M domain, from CD45, which contains four putative N-glycosylation sites. 
We provide evidence that fusing the M domain to the C- or N-termini of target proteins greatly increases recom-
binant protein production in plants. We also demonstrate that the M domain-mediated increase in protein levels 
(due to increased N-glycosylation) is specific to ER-targeted proteins and is due to increased rates of translation 
rather than transcription.
Results
Fusion of the M domain (containing multiple N-glycosylation sites) increases recombinant pro-
tein levels. To investigate the effects of N-glycosylation on the expression of recombinant proteins in plants, 
we selected a 60 amino-acid fragment from positions Ala231 to Asp290 of CD45. This fragment contains four 
putative N-glycosylation sites, which we named the M domain (Fig. 1). CD45 is a receptor-type tyrosine-protein 
phosphatase C involved in immune cell activation and differentiation that is heavily glycosylated27. For the target 
protein, we selected leptin, a hormone involved in weight control. The M domain and the small epitope HA (for 
immunodetection) were fused to the C-terminus of leptin (Fig. 2a). The leptin-M-HA fusion construct (eLepfM) 
was subsequently fused to the BiP leader sequence28, Cab transit peptide29, or presequence of the F1-ATPase 
gamma subunit30 to induce targeting to the ER, chloroplast, and mitochondria, respectively. Signal peptide, tran-
sit peptide, and presequence used in this study are 34, 87, and 77 amino acids long, respectively. After proper 
targeting into their target organelles, these signal sequences are cleaved, and 7, 35, and 29 amino acids of signal 
peptide, transit peptide and presequence, respectively, remain in leptin-HA or leptin-M-HA fusion proteins. For 
the ER-targeted construct, an ER retention signal, HDEL, was additionally fused to the C-terminus of the con-
struct. As controls, we generated constructs without the M domain for the three organelle-targeted constructs. We 
transformed these six constructs into Arabidopsis protoplasts and measured the expression levels of the recombi-
nant proteins at 24 h after transformation. We separated protein extracts from the protoplasts by SDS-PAGE and 
analyzed them by western blotting using anti-HA antibody. The apparent molecular weights of all proteins used 
in this study were larger than the expected molecular weights. Acidic amino acid residues could reduce protein 
mobility in SDS-PAGE31. Indeed, all constructs contain the enterokinase cleavage site, DDDDK.
ER- and chloroplast-targeted fusion proteins without the M domain were expressed at comparable lev-
els, whereas the expression level of the mitochondria-targeted fusion protein was half that of the ER- and 
chloroplast-targeted fusion proteins. Moreover, their apparent molecular weights indicated that these proteins 
were successfully targeted to their corresponding target organelles. By contrast, the levels of M domain-containing 
Figure 1. Amino acid sequence of the M domain. The amino acid sequence of human CD45 from Ala231 to 
Asp290 is shown. The putative N-glycosylation sites of the four Asn residues are indicated by N1 to N4.
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Figure 2. Fusion of the M domain increases the expression levels of recombinant protein. (a) Schematic 
representation of the constructs. All target sequences were expressed under the control of the cauliflower mosaic virus 
(CaMV) 35 S promoter and heat shock protein (HSP) terminator. ER-targeted proteins contain the leader sequence 
of BiP. Recombinant proteins targeted to the chloroplast or mitochondria contain the transit peptide of Cab or the 
presequence of the F1-ATPase gamma subunit, respectively. Enk, enterokinase. (b) Western blot analysis of various 
recombinant proteins. Protein extracts from protoplasts transformed with the indicated constructs were analyzed by 
western blotting using anti-HA antibody. Actin (detected using anti-actin antibody) was used as a loading control. 
EeLepf and EeLepfM are ER-targeted proteins, CeLepf and CeLepfM are chloroplast-targeted proteins, and FeLepf 
and FeLepfM are mitochondria-targeted proteins. (c) Quantification of protein levels. The intensity of protein bands 
from Fig. 2(b) was quantified using the software provided with the LAS4000 image analyzer; values relative to that of 
ER-targeted EeLepf are shown. Error bars, standard deviation (n = 3). Means with different letters indicate significant 
difference (Tukey’s test P < 0.05). (d) Schematic representation of unglycosylated mutant protein M1234. Four Asn 
residues were substituted with Gln residues as indicated. (e) Analysis of N-glycosylation. Protoplasts transformed 
with the indicated constructs were incubated for 24 h with or without tunicamycin (10 μg/mL). Protein extracts from 
transformed protoplasts were analyzed by western blotting using anti-HA antibody. (f) Quantification of protein 
levels. To quantify protein levels, the signal intensity of each band in Fig. 2(e) was measured using the software 
provided with the LAS4000 system; values relative to that of tunicamycin-untreated EeLepf (EeLepf -) are shown. 
Three independent experiments were performed. Error bar, standard deviation (n = 3). Means with different letters 
indicate significant difference (Tukey’s test P < 0.05).
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proteins differed greatly from the levels of these proteins. ER-targeted M domain-containing proteins exhib-
ited as multiple bands due to difference in N-glycosylation. To estimate the expression levels of fusion proteins, 
intensities of all protein bands except the bottom band were added because the bottom band was considered as 
non-glycosylated protein based on the protein size. Fusion of the M domain to ER-targeted leptin (EeLepfM) 
increased protein levels by 6.1-fold compared with the ER-targeted leptin without the M domain (EeLepf). 
Moreover, the expression level of ER-targeted recombinant protein EeLepfM was 4- and 6-fold higher than 
that of chloroplast-targeted CeLepfM and mitochondria-targeted FeLepfM, respectively (Fig. 2b,c). In addi-
tion, the molecular weight of ER-targeted EeLepfM was significantly higher than that of the mitochondria- and 
chloroplast-targeted proteins, indicating that ER-targeted EeLepfM was N-glycosylated. As a loading control, we 
investigated endogenous actin levels using anti-actin antibody and found that the actin levels were identical in 
all samples.
To investigate the effects of N-glycosylation on protein expression in detail, we generated a construct to 
express mutant proteins in which Asn residues were substituted with Gln residues. In the ER-targeted leptin-M 
construct, all four Asn residues in the M domain were substituted with Gln residues to give EeLepfM1234. The 
three ER-targeted constructs (EeLepf, EeLepfM, and EeLepfM1234) were transformed into Arabidopsis proto-
plasts and incubated in the presence of tunicamycin, an inhibitor of N-glycosylation32. The apparent molecular 
weight of EeLepf and EeLepfM1234 was not altered in the presence of tunicamycin, indicating that these fusion 
proteins were not N-glycosylated. In addition, tunicamycin treatment did not affect the expression levels of these 
two fusion proteins, indicating that tunicamycin itself does not affect translation levels. EeLepfM protein levels 
were greatly reduced by tunicamycin treatment, indicating that N-glycosylation strongly affects protein levels. 
EeLepfM in the tunicamycin-treated sample migrated significantly more rapidly (in SDS-PAGE) than in the 
untreated sample, confirming that EeLepfM was heavily N-glycosylated (Fig. 2e,f). These results suggest that 
N-glycosylation of the M domain increases the levels of M domain-containing fusion proteins.
To investigate the effects of the M domain on the expression levels of proteins in general, we used human leu-
kemia inhibitory factor (LIF) and green fluorescent protein (GFP) as target proteins. At the same time, to investi-
gate whether the M domain-induced increase in protein levels has a positional effect, we fused the M domain to 
the N-terminus of the target protein leptin, LIF and GFP. As controls, we generated constructs, which produces 
target proteins without the M domain (Fig. 3a). We transformed these 9 constructs into Arabidopsis protoplasts 
and subjected protein extracts from the protoplasts to SDS-PAGE and western blot analysis using anti-HA anti-
body. Expression levels of M domain-containing proteins were higher than those of each control protein. LIF is 
highly glycosylated protein and exhibits a wide range of variation in molecular weight from 20 kD to over 37 kD 
depending on the host cells33. In the cases of leptin and LIF, C-terminal M domain fusion gave higher expression 
than N-terminal M domain fusion. These results indicate that the M domain increases the levels of recombinant 
proteins regardless of position, although the degree of increase was dependent on the target proteins (Fig. 3b–d).
N-glycosylation of the M domain increases recombinant protein levels, which is strongly 
dependent on the presence of individual N-glycosylation sites and their combination. To 
obtain insight into the mechanism by which N-glycosylation increases protein levels, we examined whether 
Figure 3. M domain fusion generally increases protein expression levels regardless of the position. (a) 
Schematic representation of constructs with or without the M domain. (G4S)2 indicates a peptide linker 
containing two copies of a sequence comprising four Gly and one Ser residue. Xxx is model protein including as 
leptin (Lep), LIF (Lif), GFP (Gfp). (b–d) Expression levels of fusion proteins. Protein extracts from transformed 
protoplasts with the indicated constructs were analyzed by western blotting using anti-HA (b,c) or anti-GFP 
antibodies (d). Actin was used as a loading control.
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the N-glycosylation-mediated increase in protein levels is dependent on the number or specific positions of 
N-glycosylation sites within the M domain. We generated mutant proteins in which one, two, or three Asn resi-
dues out of the four N-glycosylation sites were substituted with the corresponding number of Gln residues. For 
mutant proteins with two or three Asn-to-Gln substitutions, all possible combinations of Asn-to-Gln substitution 
mutants were generated. We transformed these constructs into protoplasts and examined the expression levels 
of the mutant proteins by western blot analysis using anti-HA antibody (Fig. S1a–c). The expression levels are 
shown relative to the expression level of the wild-type M domain-containing protein, EeLepfM (Fig. 4). The 
protein bands for all four triple mutants were doublet and the bottom band was same size with unglycosylated 
EeLepfM1234, indicating that all four sites are glycosylated but glycosylation efficiencies differ depending on 
the potential glycosylation sites (Fig. S1c). The level of EeLepfM1234, in which all four N-glycosylation sites 
were substituted with Gln residues, was approximately 33% that of the wild-type M domain-containing pro-
tein, EeLepfM, indicating that N-glycosylation increased protein levels 3-fold compared with the wild type. 
The triple mutants containing single N-glycosylation site showed that N-glycosylation at the fourth or second 
N-glycosylation site (EeLepfM123 and EeLepfM134) increased expression levels whereas N-glycosylation at the 
third or first N-glycosylation site (EeLepfM124 and EeLepfM234) had no effect (Fig. 4c). Indeed, the expression 
level of EeLepfM13 which contained the second and fourth N-glycosylation sites was almost two fold higher than 
that of EeLepfM1234 and had no significant difference from that of fully glycosylated EeLepfM. However, the 
level of EeLepfM24 which contained the first and third N-glycosylation sites was also significantly increased com-
pared to unglycosylated EeLepfM1234 (Fig. 4b). Moreover, expression levels of all single mutants significantly 
reduced compared to fully glycosylated EeLepfM, indicating that all N-glycosylation sites had a certain degree of 
effect on the protein expression (Fig. 4a). These results suggest that any single N-glycosylation site can increase 
the expression level of proteins and that this increase may depend on the combination or specific location of 
N-glycosylation sites in the M domain. To confirm that the differences in the levels of these proteins were not due 
to differences in the transcript levels of the constructs, we performed quantitative RT-PCR analysis and found that 
the transcript levels of all 16 constructs did not show any statistical difference (Fig. S2).
N-glycosylated-induced increases in EeLepfM expression levels are due to high rates of trans-
lation. To gain insight into the mechanism underlying how N-glycosylation increases protein levels, we exam-
ined whether chaperones in the ER contribute to this increase. N-glycosylation is crucial for the proper folding 
of proteins in the ER, thereby contributing to protein expression34. Among these ER chaperones, binding protein 
(BiP) plays a critical role in N-glycosylation and protein folding34,35. To investigate the possible involvement of BiP 
in the N-glycosylation-mediated increase in protein levels, we examined the endogenous BiP levels of the samples 
by western blot analysis using anti-BiP antibody. We analyzed protein extracts from protoplasts transformed with 
glycosylated or unglycosylated constructs by western blotting using anti-BiP antibody. BiP levels did not differ 
between the two samples, indicating that BiP does not play a direct role in the N-glycosylated-induced increase 
in protein levels (Fig. S1d).
N-glycosylation plays a critical role in protein folding in the ER. Thus, unglycosylated proteins may not be 
efficiently folded in the ER. The unfolded proteins are removed from the ER and degraded in the cytosol via 
Figure 4. N-glycosylation-mediated increase in fusion protein levels is dependent on individual 
N-glycosylation sites in the M domain and their combination. (a–c) Expression levels of various Asn-to-Gln 
substitution mutants. The indicated Asn-to-Gln mutants were expressed in protoplasts. Protein extracts from 
transformed protoplasts were analyzed by western blotting using anti-HA antibody. Western blot images are 
shown in Fig. S1. The signal intensity of protein bands shown in Fig. S1 was quantified using software provided 
with the LAS4000 image analyzer; relative values to that of the ER-targeted wild-type protein, EeLepfM, are 
shown. (a) Relative levels of single Asn-to-Gln mutants; (b) double Asn-to-Gln mutants; (c) triple Asn-to-Gln 
mutants. Error bars, SD (n = 4). Numbers in these mutant constructs indicate Asn residues at the first to fourth 
position substituted with Gln. Means with different letters indicate significant difference (Tukey’s test P < 0.05).
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a mechanism known as ERAD involving ubiquitination and the 26S proteasome35. We therefore investigated 
whether unglycosylated fusion proteins are subject to ERAD. Protoplasts transformed with N-glycosylated 
EeLepfM or unglycosylated EeLepfM1234 were treated with MG132, an inhibitor of 26S proteasome-mediated 
degradation, at 18 or 21 h after transformation and further incubated for 6 or 3 h, respectively. As a positive con-
trol for MG132 treatment, protoplasts transformed with RbcS[T4,7 A]:GFP, a GFP fusion construct expressing a 
mutant form of the RbcS transit peptide defective in protein import into chloroplasts, were treated with MG132 at 
18 h after transformation and further incubated for 6 h36. RbcS[T4,7 A]:GFP is ubiquitinated and degraded by the 
26S proteasome in the cytosol. We analyzed protein extracts from the transformed protoplasts by western blotting 
using anti-HA antibody; RbcS[T4,7 A]:GFP was analyzed with anti-GFP antibody as a control. RbcS[T4,7 A]:GFP 
levels were higher in the presence versus the absence of MG132, indicating that, under our conditions, MG132 
inhibits 26S proteasome-dependent proteolysis. However, EeLepfM and EeLepfM1234 protein levels did not dif-
fer regardless of MG132 treatment (Fig. 5), indicating that ERAD does not play a role in the differences in protein 
levels of unglycosylated EeLepfM1234 versus N-glycosylated EeLepfM.
Next, we examined whether protein stability contributes to the higher levels of EeLepfM than EeLepfM1234 
in the ER. We treated protoplasts transformed with EeLepfM or EeLepfM1234 with cycloheximide, an inhibitor 
of translation37, at 12 h after transformation. We prepared protein extracts every 12 h after cycloheximide treat-
ment until 48 h after transformation and analyzed protein levels by western blotting using anti-HA antibody. 
Unglycosylated EeLepfM1234 was maintained at the comparable level until 48 h after transformation (92%), whereas 
the protein levels of EeLepfM at 48 h after transformation were reduced to only 16% those at 12 h after transforma-
tion (Fig. 6), indicating that EeLepfM1234 is more stable than EeLepfM in the ER. These results suggest that protein 
stability does not contribute to the difference in protein levels between EeLepfM1234 and EeLepfM.
The results in Figs 5 and 6 raised the possibility that the higher levels of EeLepfM versus EeLepfM1234 resulted 
from a higher rate of translation. We therefore examined the relative expression of EeLepfM versus EeLepfM1234 
at various times after protoplast transformation. The level of EeLepfM protein increased more rapidly than that of 
EeLepfM1234 (Fig. 6). To get direct evidence that N-glycosylation enhances translation rate, in vitro translation was 
performed using transcription-translation coupled wheat germ extracts system. Proteins produced in wheat germ 
extracts was not translocated into microsomal membranes because of the absence of signal recognition particle 
(SRP). Protein levels produced in wheat germ extracts were similar regardless of N-glycosylation site mutations, 
indicating that translation occurs at the same rate if protein is not N-glycosylated (Fig. S3). These results imply that 
the process involved in N-glycosylation of proteins at the ER results in the higher levels of protein production.
Discussion
In this study, we examined the effect of N-glycosylation on recombinant protein levels in plants and provide com-
pelling evidence that N-glycosylation greatly increases the level of recombinant protein production in plants. To 
investigate the effects of N-glycosylation on recombinant protein levels, we took the approach of fusing a small 
domain containing multiple N-glycosylation sites to target proteins instead of introducing N-glycosylation sites 
Figure 5. Low expression levels of unglycosylated proteins are not caused by ER-associated degradation. (a) 
Scheme of experimental design. MG132 was added to the protoplast incubation medium at 18 or 21 h after 
transformation of the indicated constructs, and the protoplasts were further incubated for 6 or 3 h, respectively. 
HAT, h after transformation. (b) Western blot analysis of proteins. Protein extracts were prepared from 
protoplasts harvested at 24 h after transformation and analyzed by western blotting using anti-HA antibody. 
RbcS[T4,7 A]:GFP was analyzed using anti-GFP antibody as a positive control for 26S proteasome-mediated 
degradation and MG132 treatment. Actin (detected using anti-actin antibody) was used as a loading control.
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to the target proteins by site-directed mutagenesis. The advantage of our approach is that the N-glycosylation 
sites are added in an extra domain, and thus are not expected to affect the structure of the target proteins we used. 
Elliot and their colleagues introduced multiple combinations of N-glycosylation sites in native leptin sequence38. 
When those leptins were expressed in Chinese hamster ovary (CHO) cells secretion of some, not all, glycosylated 
leptin was increased and GE-Leptin L4 having 5 N-glycosylation sites exhibited greater and prolonged effect 
on reducing body weight. However, introducing N-glycosylation sites into native protein did not always result 
in high expression or bioactivity. In this approach, the N-glycosylation domain is fused to the target proteins 
as a separate domain via a small linker. One advantage of this approach is that the recombinant proteins are 
not mutated within the target sequence. However, there is a caveat: the recombinant proteins contain an extra 
domain. Thus, if the production of only the native target protein is desired, the extra domain should be removed 
from the recombinant protein after it is produced in plants.
Many approaches have been taken to increase protein levels in plants. Most approaches focus on increasing 
transcript levels using either strong promoters or viral RNA or DNA amplification systems39,40. Increasing transcript 
Figure 6. The translation rate of the M domain-containing recombinant protein is higher than that of 
the mutant fusion protein containing an unglycosylated M domain. (a) Scheme of experimental design. 
Cycloheximide (CHX) or DMSO (as a control) was added to the protoplast incubation medium at 12 h after 
transformation of the indicated constructs, and protoplasts were harvested at the indicated time points. (b) 
Western blot analysis of protein levels. Protein extracts from protoplasts were analyzed by western blotting using 
anti-HA antibody. Actin (detected using anti-actin antibody) was used as a loading control. (c) Quantification 
of protein levels. The signal intensities of the protein bands in Fig. 6(b) were measured using software provided 
with the LAS4000 image analyzer and are expressed as relative values to that of the corresponding constructs in 
12 HAT samples Error bars, SD (n = 3). Repeated-measures two-way analysis of variance (ANOVA) detected a 
significant expression level difference between EeLepfM and EeLepfM1234 in the absence (DMSO) or presence 
(CHX) of cycloheximide (*p < 0.05; ***p < 0.001).
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levels contribute greatly to increasing protein levels. However, when recombinant proteins are produced in cells, 
many steps occur downstream of transcription. These steps may also contribute to high levels of protein produc-
tion. Indeed, we found that the mutations at N-glycosylation sites in the M domain of human CD45 did not alter 
the transcript levels of recombinant genes when fused to target proteins. This result raised the possibility that the 
N-glycosylation of the M domain plays a role somewhere downstream of transcription to increase protein levels.
One crucial step in protein production downstream of transcription is translation on ribosomes. Thus, trans-
lation efficiency should strongly affect the levels of proteins in the cell. However, higher levels of transcripts do not 
necessarily lead to the higher levels of proteins41,42. Moreover, the 5′ UTR upstream of the coding region greatly 
affects translational efficiency17,43; 5′ UTR sequences that affect translational efficiency include specific sequence 
motifs such as omega sequences, translational enhancers, and internal ribosome entry sites18,44,45. Insertion of 
the omega sequence leads to a several-fold increase in protein levels18. The steps after translation on ribosomes 
include targeting to organelles (in the case of organellar proteins), folding, maturation, and storage in the cell46. All 
of these steps should affect protein levels. In the current study, the presence of the M domain increased the levels 
of ER-targeted proteins, but not chloroplast- or mitochondria-targeted proteins. These results strongly suggest that 
N-glycosylation is involved in the increase in protein levels. Consistent with this idea, substituting four Asn resi-
dues with Gln residues in the M domain eliminated the M domain-mediated increase in protein levels. We cannot 
completely exclude the possibility that low levels of proteins fused with non-glycosylated M domain is due to the 
alteration of the M domain structure. At least, proteins fused with non-glycosylated M domain was more stable in 
the ER and not degraded. Fusion of the M domain to either the N- or C-termini of target proteins increased protein 
levels. Moreover, not all N-glycosylation sites were necessary to increase protein levels. In fact, even the addition of a 
single N-glycosylation site was sufficient to increase protein levels. This finding suggests that the increase in protein 
levels is not dependent on the number of N-glycosylation sites. Moreover, M domain- and its mutants-fused leptins 
except glycosylation-free mutant exhibited as multiple bands in western blot results, indicating that the efficiency of 
N-glycosylation differs depending on the potential N-glycosylation sites. In fact, the location of the N-glycosylation 
sites in the M domain or their combination (when multiple N-glycosylation sites were present in the M domain) was 
critical for increasing protein levels or glycosylation pattern. Thus, it was hard to expect the efficiency of glycosyla-
tion at each site. Currently, we were unable to propose any rule about the effects of N-glycosylation on the increase in 
protein levels. Similarly, N-glycosylation increases protein levels in yeast and Pseudomonas aeruginosa25,26. However, 
depending on the position of the N-glycosylation sites, protein levels can also be reduced by N-glycosylation26. Thus, 
the exact effect of N-glycosylation on protein levels should be determined experimentally.
What is the underlying mechanism for the N-glycosylation-mediated increase in protein levels in plants? 
N-glycosylation of ER proteins is crucial for protein folding20. We eliminated the possibility that N-glycosylation 
contributes to the stability of recombinant proteins in the ER; in fact, N-glycosylated EeLepfM was less stable than 
unglycosylated EeLepfM1234 in the ER. By contrast, the accumulation rates of N-glycosylated proteins were much 
higher than those of unglycosylated proteins. One possibility is that N-glycosylation increases the translation rate. 
In vitro translation analysis revealed that whether proteins have potential N-glycosylation sites or not they were 
expressed at the same levels when they were produced as non-glycosylated forms in wheat germ extracts. These 
results suggest that the nucleotide or amino acid sequence differences do not affect the translation rate and raise 
the possibility that a process involved in N-glycosylation at the ER is crucial for high translation rate. However, 
how N-glycosylation affects the translation rate is currently unclear. Perhaps N-glycosylation facilities the folding of 
nascent proteins in the ER, which in turn leads to a higher rate of translation on ribosomes. The exact mechanism 
by which N-glycosylation enhances the translation rate of ER proteins should be further investigated in the future.
High levels of recombinant protein expression are essential for the successful use of plants as protein produc-
tion systems. Much effort has been devoted to increasing the transcript levels of target genes to increase recom-
binant protein levels8. In this study, we developed a new approach in which N-glycosylation is used to increase 
recombinant protein levels in plants. Fusion of a domain containing multiple N-glycosylation sites to the N- or 
C-termini of target proteins greatly increases protein levels.
Experimental Procedures
Plant materials and growth conditions. Arabidopsis (Arabidopsis thaliana ecotype, Col-0) plants were 
grown on B5 plates in a growth chamber at 20 °C to 22 °C under a 16 h/8 h light/dark cycle. Leaf tissues from 
2-week-old plants were used for protoplast isolation.
Plasmid construction. The mature peptide region of mouse leptin cDNA (NM_008493.3) was used. The 
DNA fragment encoding the M domain was synthesized by repetitive polymerase chain reaction (PCR), and all 
combinations of Asn-to-Gln substitution mutants were generated by PCR-based site-directed mutagenesis. The 
mature peptide region of human LIF cDNA (NM_002309.4) was amplified by PCR. Enterokinase and furin cleav-
age sites were included in the primer used for leptin amplification. The HA epitope and ER retention signal HDEL 
were introduced by the primer used for M domain amplification. The sequences of primers used in this study are 
listed in Table S1. PCR products of the mature region of leptin and the M domain, including Asn-to-Gln sub-
stitution mutants, were sequentially ligated into the vector BiP:HA:CBD:HDEL28. To generate chloroplast- and 
mitochondria-targeted constructs, the Cab transit peptide or the F1-ATPase gamma subunit presequence was 
amplified by PCR and substituted with BiP in the EeLepf and EeLepfM vector29,30. All constructs were generated 
with the same vector, thus 5′-UTRs were same for all constructs (5′-ATTATTACATCAAAACAAAAA-3′)17. The 
sequences of all PCR products were verified by nucleotide sequencing.
Transient expression, chemical treatments, and western blot analysis. Plasmids were intro-
duced into protoplasts by polyethylene glycol-mediated transformation47. Protein extracts were prepared at 24 h 
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after transformation or at the indicated time points48. The protoplasts were treated with tunicamycin (10 μg/mL; 
Sigma-Aldrich, St. Louis, MO) immediately after transformation. Cycloheximide (50 μg/mL; Sigma-Aldrich, St. 
Louis, MO) treatment was applied at 12 h after transformation. Protein extracts were analyzed by western blot-
ting with anti-HA (Roche Diagnostics, Indianapolis, IN), anti-actin (MP Biomedicals, Solon, OH), anti-GFP 
(Bio-Application, Pohang, Korea), or anti-BiP antibodies47–49. The protein blots were developed with an ECL 
kit (Amersham Pharmacia Biotech, Piscataway, NJ), and images were obtained using an LAS4000 image ana-
lyzer (Fujifilm, Tokyo, Japan). To quantify expression levels, intensity of protein bands in western blot images 
was measured using Multi-Gauge program equipped to LAS4000 image analyzer (FUJIFILM, Tokyo, Japan). 
Band intensities were added in cases of glycosylated proteins except the bottom band that was considered as the 
non-glycosylated form.
Total RNA isolation and quantitative RT-PCR analysis of transcript levels. Total RNA was 
extracted from protoplast after PEG transformation using the Ambion Phenol-free total RNA isolation kit and 
treated with TURBO DNase (Ambion). cDNA was synthesized using the high-capacity cDNA reverse transcrip-
tion kit (Applied Biosystems). Power SYBR Green PCR Master Mix (Applied Biosystems) was used to detect tran-
script levels. ACTIN2 was used as an endogenous control. The PCR mixture (20 μL) contained 50 ng of template, 
0.5 mM forward and reverse primers, and 1X SYBR Mix. The PCR conditions were as follows: initial denaturation 
at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. To confirm specific amplification, 
a melting curve was generated by heating at 95 °C for 15 s and then at 60 °C for 1 min, and then increasing the 
temperature by 0.3 °C every 15 s up to 95 °C.
In vitro translation assay. For in vitro translation, DNA fragments from start codon to stop codon of 
EeLepfM and EeLepfM1234 were ligated into pCS2++ vector harboring SP6 promoter and SV40 terminator. 
PCR was performed to generate linearized DNA using primers, SP6 promoter-339bp-F and SV40 terminator-R. 
In vitro translation assay was performed using transcription and translation coupled wheat germ extracts system 
following manufacture’s protocol (Promega).
Statistical analysis. Data in graphs are expressed as means and error bars represent standard deviation 
(SD). To quantify protein expression levels, we measured intensity of protein bands in western blot images from at 
least three biological replicates. Statistical analyses were performed using one-way analysis of variance (ANOVA) 
followed by a post hoc Tukey’s test with P < 0.05 to be considered significant or repeated-measures two-way 
ANOVA.
Data availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary information files).
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